Fed. Circ. Says UT's Immunity Can't Halt Cancer Patent Suit

Law360 (July 24, 2020, 8:18 PM EDT) -- A splintered Federal Circuit panel ruled Friday that sovereign immunity prohibits the University of Texas from being involuntarily made a plaintiff in a suit that a licensee of its cancer therapy patents filed against Baylor College of Medicine, but that the case can proceed anyway.

The court issued an unusual ruling where all three judges on the panel filed separate opinions disagreeing on key issues, but two of them concurred that a Southern District of Texas judge wrongly dismissed the suit by UT's licensee, Gensetix Inc., after the university refused to participate.

The lower court was correct in its decision that...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!